The Latin America, Middle East and Africa Atrial Fibrillation Market would witness market growth of 11.7% CAGR during the forecast period (2022-2028).
Direct cardiac auscultation is advised for establishing the heart rate in atrial fibrillation. The most serious indication that needs quick attention is low blood pressure. Due to the decreased cardiac output, many of the symptoms of untreated atrial fibrillation are signs of congestive heart failure. When respiratory distress is present, the affected person's breathing rate frequently rises.
Using pulse oximetry, any precipitating causes, such as pneumonia, may be linked to insufficient oxygen reaching the body's tissues. A jugular vein examination may demonstrate increased pressure (jugular venous distention). When the lungs are examined, crackles may be heard which might be signs of pulmonary edema. A quick, uneven beat will be visible during a cardiac examination.
Although it can happen in otherwise healthy hearts, atrial fibrillation is associated with several cardiovascular diseases. High blood pressure, coronary artery disease, mitral valve stenosis (caused, for example, by rheumatic heart disease or mitral valve prolapse), left atrial enlargement, congenital heart disease, mitral regurgitation, hypertrophic cardiomyopathy (HCM), pericarditis, and prior heart surgery are among the cardiovascular conditions known to be linked to the development of atrial fibrillation.
Reviewing epidemiological research on tobacco use prevalence, related health impacts, and strategies for smoking cessation and prevention in the United Arab Emirates was the goal. By increasing the expense of smoking through taxing, launching persistent social marketing programs, and guaranteeing that health experts regularly counsel smokers to stop smoking together with behavioural and pharmaceutical assistance for cessation, the UAE Government has shown great efforts.
The Brazil market dominated the LAMEA Atrial Fibrillation Market by Country in 2021; thereby, achieving a market value of $62.5 million by 2028. The Argentina market is experiencing a CAGR of 12.3% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 11.4% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on Type, the market is segmented into Surgical and Non-Surgical. Based on Technology, the market is segmented into Radiofrequency, Laser, Cryotherapy, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Atrial Fibrillation Market is Predict to reach $2.7 Billion by 2028, at a CAGR of 9.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, Abbott Laboratories, Medtronic PLC, BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Siemens Healthineers AG (Siemens AG) and AtriCure, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals
- Specialty Clinics
- Others
By Type
By Technology
- Radiofrequency
- Laser
- Cryotherapy
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- Abbott Laboratories
- Medtronic PLC
- BIOTRONIK SE & Co. KG
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- AtriCure, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Atrial Fibrillation Market, by End User
1.4.2 LAMEA Atrial Fibrillation Market, by Type
1.4.3 LAMEA Atrial Fibrillation Market, by Technology
1.4.4 LAMEA Atrial Fibrillation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jun – 2022, Jan) Leading Players
Chapter 4. LAMEA Atrial Fibrillation Market by End User
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Specialty Clinics Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Atrial Fibrillation Market by Type
5.1 LAMEA Surgical Market by Country
5.2 LAMEA Non-Surgical Market by Country
Chapter 6. LAMEA Atrial Fibrillation Market by Technology
6.1 LAMEA Radiofrequency Market by Country
6.2 LAMEA Laser Market by Country
6.3 LAMEA Cryotherapy Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Atrial Fibrillation Market by Country
7.1 Brazil Atrial Fibrillation Market
7.1.1 Brazil Atrial Fibrillation Market by End User
7.1.2 Brazil Atrial Fibrillation Market by Type
7.1.3 Brazil Atrial Fibrillation Market by Technology
7.2 Argentina Atrial Fibrillation Market
7.2.1 Argentina Atrial Fibrillation Market by End User
7.2.2 Argentina Atrial Fibrillation Market by Type
7.2.3 Argentina Atrial Fibrillation Market by Technology
7.3 UAE Atrial Fibrillation Market
7.3.1 UAE Atrial Fibrillation Market by End User
7.3.2 UAE Atrial Fibrillation Market by Type
7.3.3 UAE Atrial Fibrillation Market by Technology
7.4 Saudi Arabia Atrial Fibrillation Market
7.4.1 Saudi Arabia Atrial Fibrillation Market by End User
7.4.2 Saudi Arabia Atrial Fibrillation Market by Type
7.4.3 Saudi Arabia Atrial Fibrillation Market by Technology
7.5 South Africa Atrial Fibrillation Market
7.5.1 South Africa Atrial Fibrillation Market by End User
7.5.2 South Africa Atrial Fibrillation Market by Type
7.5.3 South Africa Atrial Fibrillation Market by Technology
7.6 Nigeria Atrial Fibrillation Market
7.6.1 Nigeria Atrial Fibrillation Market by End User
7.6.2 Nigeria Atrial Fibrillation Market by Type
7.6.3 Nigeria Atrial Fibrillation Market by Technology
7.7 Rest of LAMEA Atrial Fibrillation Market
7.7.1 Rest of LAMEA Atrial Fibrillation Market by End User
7.7.2 Rest of LAMEA Atrial Fibrillation Market by Type
7.7.3 Rest of LAMEA Atrial Fibrillation Market by Technology
Chapter 8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.2 MicroPort Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Approvals and Trials:
8.3 Medtronic PLC
8.3.1 Company overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Approvals and Trials:
8.4.6 SWOT Analysis
8.5 BIOTRONIK SE & Co. KG
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Approvals and Trials:
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Approvals and Trials:
8.6.6 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.7.5.3 Geographical Expansions:
8.8 Siemens Healthineers AG (Siemens AG)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Product Launches and Product Expansions:
8.8.5.2 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 AtriCure, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.5.2 Acquisition and Mergers:
8.9.5.3 Approvals and Trials:
TABLE 1 LAMEA Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Atrial Fibrillation Market
TABLE 4 Product Launches And Product Expansions – Atrial Fibrillation Market
TABLE 5 Acquisition and Mergers – Atrial Fibrillation Market
TABLE 6 Approvals and Trials – Atrial Fibrillation Market
TABLE 7 LAMEA Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 8 LAMEA Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 9 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 16 LAMEA Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 17 LAMEA Surgical Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Surgical Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Non-Surgical Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Non-Surgical Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 22 LAMEA Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 23 LAMEA Radiofrequency Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Radiofrequency Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Laser Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Laser Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Cryotherapy Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Cryotherapy Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Atrial Fibrillation Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Atrial Fibrillation Market by Country, 2022 - 2028, USD Million
TABLE 33 Brazil Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 34 Brazil Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 35 Brazil Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 36 Brazil Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 37 Brazil Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 38 Brazil Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 39 Brazil Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 40 Brazil Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 41 Argentina Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 42 Argentina Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 43 Argentina Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 44 Argentina Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 45 Argentina Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 46 Argentina Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 47 Argentina Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 48 Argentina Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 49 UAE Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 50 UAE Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 51 UAE Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 52 UAE Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 53 UAE Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 54 UAE Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 55 UAE Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 56 UAE Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 63 Saudi Arabia Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 64 Saudi Arabia Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 65 South Africa Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 66 South Africa Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 67 South Africa Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 68 South Africa Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 69 South Africa Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 70 South Africa Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 71 South Africa Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 72 South Africa Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 73 Nigeria Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 74 Nigeria Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 75 Nigeria Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 76 Nigeria Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 77 Nigeria Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 78 Nigeria Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 79 Nigeria Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 80 Nigeria Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 85 Rest of LAMEA Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 86 Rest of LAMEA Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 87 Rest of LAMEA Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 88 Rest of LAMEA Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 89 Key information – Johnson & Johnson
TABLE 90 key Information – MicroPort Scientific Corporation
TABLE 91 Key Information – Medtronic PLC
TABLE 92 key Information – Boston Scientific Corporation
TABLE 93 Key Information – BIOTRONIK SE & Co. KG
TABLE 94 Key Information – Abbott Laboratories
TABLE 95 Key Information – Koninklijke Philips N.V.
TABLE 96 Key Information – Siemens Healthineers AG
TABLE 97 Key Information – AtriCure, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jun – 2022, Jan) Leading Players
FIG 5 Recent strategies and developments: MicroPort Scientific Corporation
FIG 6 Swot analysis: Medtronic plc
FIG 7 Recent strategies and developments: Boston Scientific Corporation
FIG 8 SWOT Analysis: Boston Scientific Corporation
FIG 9 Swot analysis: Abbott laboratories
FIG 10 Recent strategies and developments: Koninklijke Philips N.V.
FIG 11 Recent strategies and developments: Siemens Healthineers AG
FIG 12 Swot analysis: Siemens AG
FIG 13 Recent strategies and developments: AtriCure, Inc.